Skip to main content

Your search for “Liver Disease” returned 200 results

UC San Diego Health Performs First HIV-to-HIV Kidney Transplant in Region

August 27, 2019

For the first time in Southern California, surgeons at UC San Diego Health have transplanted the kidney of a deceased donor with HIV into a recipient with a pre-existing HIV infection. The procedure is part of an unprecedented multi-site national clinical trial.

Powered by Donated Parts

June 23, 2022

…of four receives lifesaving liver transplant from his brother through UC San Diego Health’s live liver donation program The Partridge brothers have spent the past 20 years living thousands of miles apart—Mike in Kidderminster, England where they both grew up, and Andy in the United States, now residing in San…

Too Much of a Good Thing May Lead to Too Much of a Liver As Well

February 24, 2020

UC San Diego researchers suggest that prolonged exposure to a pair of antioxidant proteins may contribute to enlargement of the liver and fatty liver diseases.

UC San Diego and Samsara Sciences Team Up to Advance Liver Tissue Models

January 14, 2016

…techniques and methods for the isolation and characterization of liver cells that will help drive new research on liver biology, drug safety and efficacy, and the treatment of liver diseases.

Phage Therapy Shows Promise Beyond Treating Infections

November 14, 2019

…classic bacterial infection: alcoholic liver disease. Bacteriophages are viruses that specifically destroy bacteria. In the early 20th century, researchers experimented with phages as a potential method for treating bacterial infections. But then antibiotics emerged and phages fell out of favor. With the rise of antibiotic-resistant infections, however, researchers have renewed…

Immune Cell Identity Crisis: What Makes a Liver Macrophage a Liver Macrophage?

October 3, 2019

UC San Diego researchers investigated how a type of immune cell called a macrophage becomes specialized to the liver. Their study, published October 3, 2019 in Immunity, sets the stage for understanding how macrophage specialization gets disrupted by — or contributes to — liver disease.

UC San Diego Partners with Janssen to Research New Approaches to Treat Metabolic Diseases

June 15, 2017

University of California San Diego School of Medicine has entered a five-year strategic partnership with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover meaningful treatments for metabolic diseases.

Birth Weight is Risk Factor for Fatty Liver Disease in Children

April 4, 2017

…and high birth weights in developing Non Alcoholic Fatty Liver Disease (NAFLD), a chronic disease that often leads to a need for organ transplantation.

New Drug Successfully Halts Fibrosis in Animal Model of Liver Disease

August 7, 2012

A study published in the online journal Hepatology reports a potential new NADPH oxidase (NOX) inhibitor therapy for liver fibrosis, a scarring process associated with chronic liver disease that can lead to loss of liver function.

UC San Diego Health and Sharp HealthCare Announce Joint Liver Transplantation Program

January 11, 2016

UC San Diego Health and Sharp HealthCare have formed a joint program to enhance liver transplantation service¬¬s in San Diego by combining resources, collaborating on research and expanding specialized liver care. The alliance is expected to strengthen clinical services for patients with end-stage liver disease while reducing costs.

Category navigation with Social links